Ptc Therapeutics

PTCTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.505 B

$65.96 +1.07%

Close of 22 Sept 2026

Revenue

$1.73B

#1226 by revenue

Earnings

$683.0M

#508 by earnings

Shares outstanding

83,460,802

Latest filing cover page

P/E ratio

8.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#51Travere TherapeuticsTVTX$5.68B
#52Cogent BiosciencesCOGT$5.66B
#53Ptc TherapeuticsPTCT$5.51B
#54Dianthus TherapeuticsDNTH$5.50B
#55ErascaERAS$5.44B

What if Ptc Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$362,253.52

Per share 5,492× higher

Bitcoin $1.74T

$20,867.94

Per share 316× higher

Nvidia $5.52T

$66,088.11

Per share 1,002× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Ptc Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.